• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SD filed by Stem Inc.

    6/2/25 4:05:44 PM ET
    $STEM
    Industrial Machinery/Components
    Miscellaneous
    Get the next $STEM alert in real time by email
    SD 1 d24133dsd.htm SD SD
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM SD

     

     

    SPECIALIZED DISCLOSURE REPORT

     

     

    Stem, Inc.

    (Exact name of the registrant as specified in its charter)

     

     

     

    Delaware   001-39455   85-1972187

    (State or other jurisdiction of

    incorporation or organization)

      (Commission File
    Number)
      (I.R.S. Employer
    Identification No.)

    4 Embarcadero Ctr., Suite 710, San Francisco, California, 94111

    (Address of principal executive offices) (Zip code)

    Saul R. Laureles

    Chief Legal Officer and Corporate Secretary

    1-877-374-7836

    (Name and telephone number, including area code, of the person to contact in connection with this report.)

     

     

    Check the appropriate box to indicate the rule pursuant to which this Form is being submitted, and provide the period to which the information in this Form applies:

     

    ☒

    Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2024.

     

    ☐

    Rule 13q-1 under the Securities Exchange Act (17 CFR 240.13q-1) for the fiscal year ended ______ .

     

     
     


    Section 1 - Conflict Minerals Disclosure

    Items 1.01 and 1.02 Conflict Minerals Disclosure and Report; Exhibit

    Conflict Minerals Disclosure

    In accordance with Rule 13p-1 under the Securities Exchange Act of 1934, as amended, Stem, Inc. (the “Company”) has filed this Specialized Disclosure Report and the Conflict Minerals Report attached hereto as Exhibit 1.01 for the calendar year ended December 31, 2024. Both of these documents are publicly available on the investor relations page of the Company’s website at: investors.stem.com.*

    Section 2 - Resource Extraction Issuer Disclosure

    Item 2.01 Resource Extraction Issuer Disclosure and Report

    Not applicable.

    Section 3 - Exhibits

    Item 3.01 Exhibits

    Exhibit 1.01 - Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

    * * * * *

     
    *

    The reference to the Company’s website is provided for convenience only, and its contents are not incorporated by reference into this Form SD or the Conflict Minerals Report, nor deemed filed with the Securities and Exchange Commission.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

    STEM, INC.

     

    By:   /s/ Saul R. Laureles
    Name: Saul R. Laureles
    Title: Chief Legal Officer and Corporate Secretary

    Date: June 2, 2025

    Get the next $STEM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $STEM

    DatePrice TargetRatingAnalyst
    4/14/2025Buy → Neutral
    UBS
    8/9/2024$2.00 → $0.50Positive → Neutral
    Susquehanna
    8/7/2024$4.00 → $1.00Buy → Hold
    TD Cowen
    3/22/2024$5.50 → $2.50Buy → Neutral
    Goldman
    2/29/2024$7.00 → $5.00Outperform
    TD Cowen
    11/3/2023Buy → Neutral
    Guggenheim
    10/20/2023$5.00Neutral
    Exane BNP Paribas
    9/6/2023$12.00 → $8.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings